Shrikant Nema*

Hony Professor Pathology and PG Director, Amaltas Institute of Medical Science Dewas (MP), India

*Corresponding Author: Shrikant Nema, Hony Professor Pathology and PG Director, Amaltas Institute of Medical Science Dewas (MP), India.

Received: December 27, 2022; Published: March 28, 2023

FNA Cytology has been a well accepted outpatient procedure for preoperative breast lesions. At the upfront it is adopted to delineate the benign and malignant lesions. It is satisfactory, sensitive and specific and well accepted by patients as well as surgeons [1]. A study undertaken in our institute, also considered the recommendations of the Bethesda conference, looked at the aspirate for five categories: Unsatisfactory smears, benign, atypical/intermediate, suspicious for malignancy and malignant. However the emphasis was put on the features such as, Cellular morphology and arrangement, nuclear character, number of mitosis, and background. It is well experienced that the number of epithelial cell clusters could be an important factor in lowering the false-negative diagnosis rate in all breast lesions.

References

1. Hunt CM., et al. “Cytological grading of breast carcinoma – A feasible proposition?” Cytopathology 1 (1990): 287‑295.
2. Taniguchi E., et al. “Cytologic grading of Invasive breast Carcinoma. Correlation with clinoco pathologic variables and predictive value of nodal metastasis”. Acta Cytology 37 (1993): 361-366.
3. Krithiga Kuppusamy., et al. “Cytological Grading of Breast Tumours—The Human and Canine Perspective”. Frontiers in Veterinary Science 6 (2019): 283.
4. Cherry Bansal., et al. “Grading systems in the cytological diagnosis of breast cancer: A review”. 10.4 (2014): 839-845.
5. The uniform approach to breast fine needle aspiration biopsy. “National Cancer Institute Fine - Needle Aspiration of Breast Workshop Subcommittees”. Diagnostic Cytopathology 16 (1997): 295-311.
6. Schwartz GF., et al. “Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of breast, April 26-28,2003, Philadelphia, PA”. Human Pathology 35 (2004): 781-784.
7. Robinson IA., et al. “Prognostic value of cytologic grading of fine needle aspirates from breast carcinomas”. Lancet 343 (1994): 947-949.
8. Yu GH., et al. “Tumour cell (dys) cohesion as a prognostic factor in aspirate smears of breast carcinoma”. American Journal of Clinical Pathology 109 (1998): 315-319. 

Citation

Citation: Shrikant Nema. “Grading of Breast Tumours on Smear Cytology" Acta Scientific Cancer Biology 7.2 (2023): 08-10.

Copyright

Copyright: © 2023 Shrikant Nema. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.